Finance

Lists
A1LB34:BVMF
Albemarle Corp Bdr
R$27.45
+2.46%
(+0.66) 1D
Aug 7, 4:56:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1LB34...
Open
R$27.00
High
R$28.01
Low
R$27.00
Mkt. cap
15.47B
Avg. vol.
0.00
Volume
80.00
52-wk high
R$45.07
52-wk low
R$16.11
Shares outstanding
118.01M
No. of employees
8K
Open
R$27.00
High
R$28.01
Low
R$27.00
Mkt. cap
15.47B
Avg. vol.
0.00
Volume
80.00
52-wk high
R$45.07
52-wk low
R$16.11
Shares outstanding
118.01M
No. of employees
8K
News stories
From sources across the web
Profile
Albemarle Corporation is an American specialty chemicals manufacturing company based in Charlotte, North Carolina. It serves several different industries including Agriculture/Food, Automotive/EV, Aviation/Aerospace, Building/Construction, Conventional Energy, Electronics, Grid Storage, and Industrial Processes. The company reported over $5.4 Billion in revenue in 2024. As of April 2025, Albemarle was the fourth highest grossing producer of Lithium, falling behind Rio Tinto, Sociedad Química y Minera, and Ganfeng Lithium. Albemarle is a large developer of flame retardant chemicals technologies, with production plants in the United States, China, the Netherlands, Belgium, Germany, France, Austria, and the United Kingdom. It also has a line of antioxidants and blends which concentrate on improving storage life and stability of fuel and other lubricant products. It produces products used in rigid and flexible polyurethane foam applications and ammonium polyphosphate products, pigments for paper applications, aluminium oxides used for flame-retardant, polishing, catalyst, and niche ceramic applications, as well as magnesium hydroxide mainly used as a flame-retardant. Wikipedia
About Albemarle Corp Bdr
CEOJ Kent Masters
Employees7.8K
FoundedFeb 28, 1994
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.31B
1.43B
1.43B
1.74B
Cost of goods sold
1.19B
1.23B
927.76M
1.15B
Cost of revenue
1.19B
1.23B
927.76M
1.15B
Research and development expenses
12.67M
12.18M
9.17M
3.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
133.78M
158.24M
137.67M
107.46M
Operating expense
146.46M
170.42M
146.84M
111.13M
Total operating expenses
1.34B
1.40B
1.07B
1.26B
Operating income
-28.84M
32.31M
354.13M
483.07M
Other non operating income
39.88M
179.27M
76.45M
14.50M
EBT including unusual items
-178.51M
-244.43M
350.49M
593.21M
EBT excluding unusual items
1.54M
37.70M
465.38M
613.78M
Income tax expense
-30.56M
157.33M
21.51M
94.00M
Effective tax rate
17.12%
-64.37%
6.14%
15.85%
Other operating expenses
-
-
-
-
Net income
-160.69M
-414.18M
319.09M
479.96M
Net profit margin
-12.29%
-29.00%
22.33%
27.53%
Earnings per share
-0.19
-0.53
2.95
3.75
Interest and investment income
-
-
-
-
Interest expense
-50.96M
-50.30M
-45.71M
-30.92M
Net interest expenses
-50.96M
-50.30M
-45.71M
-30.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
135.64M
196.02M
511.94M
638.87M
Gain or loss from assets sale
-
-
95.02M
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps